SEATTLE, WA (March 22, 2020) - KitoTech Medical, a medical device company, announces the addition of a microMend® Combo Pack to its growing line of consumer products. This product gives consumers more options to treat wounds and expands the use of microMend to close smaller lacerations and serious cuts on the fingers and discrete areas of the face. These are common and challenging areas to treat with existing wound closure products. 

The new microMend combo pack contains novel Extra Small Devices together with our currently marketed Small Devices. The Extra Small Devices are designed to close smaller wounds on the fingers, nose, ears, and around the mouth and eyes. The Small Devices in the package can be used to treat wounds elsewhere on the body. In addition, the two different size devices can be used in combination to close longer wounds. 

“We are excited to introduce the new Extra Small Device with the Combo Pack which provides consumers with the flexibility to close typical wounds as well as those that are difficult to treat. KitoTech is committed to offering a family of microMend products that addresses the increasing demand for treating lacerations at home and other settings rather than emergency rooms and urgent care clinics,” said Dr. Ron Berenson, President and CEO of KitoTech Medical. “The Combo Pack is an important addition to our portfolio of consumer products.”

SEATTLE, WA (March 18, 2021) - KitoTech Medical, a Seattle-based medical device company, announced today that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,939,912 entitled “MICROSTRUCTURE-BASED SYSTEMS, APPARATUS, AND METHODS FOR WOUND CLOSURE.” The patent is directed at key features of the company’s microMend® wound closure products that are based on the company’s proprietary Microstaple technology. KitoTech also has an issued patent in Europe and a newly granted patent in Japan on its microMend products.
​
“We are excited to have the issuance of our second U.S. patent which further strengthens the IP position for microMend products. The new patent expands our IP to protect novel aspects of the products that are essential for optimal wound closure. We believe that microMend is revolutionary in the field of wound closure and are committed to building a strong IP position for our fundamental technology and microMend products,” says Dr. Ronald Berenson, President and CEO of KitoTech Medical. 

SEATTLE (PRWEB) MARCH 10, 2021
KitoTech Medical, a Seattle-based medical device company, announced today that it has completed $4.5 million convertible note financing, which will be used to build its commercial organization to drive sales of its microMend® family of wound closure products.

With this funding, the company will expand its sales organization to market and sell microMend products to increasing numbers of physicians, hospitals, and clinics. In addition, the financing will provide the resources to allow KitoTech to introduce microMend into many additional clinical specialties, including orthopedics, obstetrics and gynecology, and general surgery. The financing will also support commercial activities in the consumer market, where there has been rapid sales growth since introducing microMend products into this segment a few months ago.
​
“microMend has demonstrated that it is faster and easier to use than sutures and provides superior cosmetic results. It is being adopted by large numbers of physicians and hospitals. With the funding from the current round, we plan to build our sales team and give more doctors and patients the opportunity to experience the many benefits of microMend,” says Dr. Ronald Berenson, President and CEO of KitoTech Medical. “In addition, we have witnessed extraordinary sales growth of our microMend products in the consumer market. With support from this financing, we will begin to build a sales organization to provide the resources needed to grow our B2C sales in this exciting new market for microMend.”

SEATTLE (PRWEB) MARCH 01, 2021
KitoTech Medical, a Seattle-based medical device company, announces the launch of a new family of wound closure products, microMend FLEX+™. The products have the same general design of other microMend® products, but are more elastic and ultra-flexible. This makes microMend FLEX+ ideal for closing wounds over joints and allows it to mold to the skin in areas with varying architecture, such as the abdomen, chest, breast, face, hands, and fingers. The first microMend FLEX+ product, microMend FLEX+ WIDE, is intended for closing longer incisions in orthopedics (joint surgeries), abdominopelvic surgeries, cardiothoracic surgeries, Caesarean sections, and plastics (breast, extremities, and abdomen).
​
“We are excited about the new breakthrough design of the microMend FLEX+ series, which adds high levels of flexibility and elasticity to our growing line of products. These features make microMend FLEX+ especially useful to close wounds in areas of the body subject to high levels of motion and stress. Its elasticity also allows microMend FLEX+ to conform to complex skin surface geometries, which are often encountered in surgery,” said Ron Berenson, MD, President and CEO. “We are first introducing the microMend FLEX+ WIDE, which enables rapid and secure closure of longer incisions associated with joint surgeries, Caesarean sections, and many other procedures – reducing closure times by 10-15 minutes. Given the high costs of ORs and similar facilities, this translates into savings of hundreds of dollars,” Dr. Berenson continued.

SEATTLE (PRWEB) OCTOBER 29, 2020
KitoTech Medical, Inc. has been awarded a group purchasing agreement for Non-Invasive Skin Closure Devices with Premier. Effective November 1, 2020, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for microMend Skin Closure Products.

Premier is a leading healthcare improvement company, uniting an alliance of more than 4,100 U.S. hospitals and 200,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.
​
“We are excited to have Premier select our microMend wound closure products for placement in their “new” Non-Invasive Skin Closure Device Category. We believe that Premier can provide an opportunity to help our new technology serve the members of all the Premier Acute and Non-Acute Care Facilities throughout the U.S.,” said Deon Miller, KitoTech’s Chief Commercial Officer.

Dr. Ronald Berenson, President and CEO of KitoTech, stated, “Similar to KitoTech, Premier is focused on improving the quality and lowering the costs of healthcare. They have an outstanding reputation and relationships with an extensive network of hospitals, clinics, and other medical facilities. We are confident that they will make microMend a valuable addition to the care of the many patients that are treated by their providers.”

SEATTLE, WA (October 12, 2020) - KitoTech Medical and MyMedic announce today that that they have formed a partnership to sell microMend’s consumer products for use in first aid and other emergency settings. Under terms of the agreement, KitoTech and MyMedic will collaborate to make and assemble the products.  MyMedic will be responsible for selling the products as additions to its first aid kits, MedPacks™, and other supplies as well as stand-alone products. The first microMend products under the partnership are expected to be introduced onto the market in November.

“With its easy application and removal, microMend’s consumer products have been widely adopted by many people to treat lacerations and other serious wounds outside of hospitals and other medical facilities. Given this success, we believe that there is a great opportunity for microMend in the first aid market. We are excited to form a partnership with MyMedic, one of the leading first aid companies. They have both the expertise and commercial footprint to successfully launch microMend into this growing market,” says Deon Miller, KitoTech Chief Commercial Officer.

David Barlow, CEO of MyMedic™, stated, "At MyMedic, we are continually curating the best, most innovative, and pro-grade First Aid supplies to the public. microMend is the perfect addition to the MyMedic arsenal of life-saving necessities. This product's convenience and simplicity align so well with our core mission; to help people be as prepared as possible. We know the public will appreciate having access to microMend and all the benefits it provides."

About microMend®
microMend consists of an array of miniature stainless-steel staples (Microstaples) attached to an adhesive backing that combines the holding strength of a suture with the simplicity of applying a bandage. It represents an easy-to-use, time-saving, and cost-effective option for closing lacerations, skin tears, surgical incisions, and other wounds.  microMend’s consumer products make it possible for people to treat lacerations at home, in the outdoors or elsewhere, and avoid ER or Urgent Care Clinic visits. microMend’s medical products are being used in the ER, Urgent Care Clinics, and Operating Rooms throughout the US.

About MyMedic™
A family operated First Aid Kits, Supplies, and Training company based on the objective to save lives, and is driven by a goal to prepare everyone with equipment and training for the unexpected emergency. Based out of Salt Lake City, Utah, MyMedic believes everyone should have instant access to a life-saving First Aid Kit. Visit https://mymedic.com to learn more.